Discounted Cash Flow Rating

Strong Sell

Return on Equity Rating

Strong Buy

Debt to Equity Rating

Strong Sell

Price to Earnings Rating

Buy

Analyst Rating

Neutral

Simple Moving Average

Neutral

Exponential Moving Average

Neutral

Relative Strength Index

Strong Buy

Standard Deviation

Strong Buy

Williams %R

Strong Buy

Average Directional Index

Neutral

Insider Trading

Neutral

Wall Street Data Solutions Rating

Neutral

B

Trinity Biotech plc (TRIB)

https://www.trinitybiotech.com

Trinity Biotech PLC is in the business of development, manufacturing, and marketing clinical diagnostic products for clinical laboratory and point of care sections of the diagnostic market. Its products are used to detect autoimmune, infectious, sexually transmitted diseases, diabetes, and disorders of the liver and intestine. The company also provides raw materials to the life sciences and research industries globally. It markets products under the brand names Recombigen, Unigold, MarBlot, Mardx, Premier, Immublot, EZ, Capita, and others. Geographically, it has two segments namely the Americas, and Rest of World - Ireland of which it derives a majority of its revenues from the Americas segment.

Current Price

---.--

% Change Today

0.00%

Change Amt. Today

0.00

Active Status

Active

Listing Date

08/18/1995

Market Cap

19,501,145

Shares Outstanding

152,830,000

Weighted SO

38,207,571

Total Employees

N/A

Upcoming Earnings

10/01/2024

Similar Tickers

STRRP --.--%

LAB --.--%

GTH --.--%

BDSX --.--%

NDRA --.--%

SERA --.--%

OLK --.--%

FONR --.--%

STIM --.--%

Beta

1.3060

Last Div

0.0000

Range

1.49-4.6

Chg

-0.0700

Avg Vol

52856

Mkt Cap

19501145

Exch

NASDAQ

Country

IE

Phone

353 1 276 9800

DCF Diff

3.6080

DCF

-1.5780

Div Yield

0.0000

P/S

0.3439

EV Multiple

-7.7753

P/FV

-0.9005

Div Yield %

0.0000

P/E

-0.9561

PEG

-0.0198

Payout

0.0000

Current Ratio

2.0177

Quick Ratio

1.0252

Cash Ratio

0.2531

DSO

113.3999

DIO

215.8356

Op Cycle

329.2356

DPO

195.6484

CCC

133.5872

Gross Margin

0.3247

Op Margin

-0.4569

Pretax Margin

-0.5972

Net Margin

-0.3796

Eff Tax Rate

-0.0006

ROA

-0.2384

ROE

1.1379

ROCE

-0.3839

NI/EBT

0.6357

EBT/EBIT

1.3070

EBIT/Rev

-0.4569

Debt Ratio

0.8341

D/E

-3.2955

LT Debt/Cap

1.4520

Total Debt/Cap

1.4356

Int Coverage

-3.2961

CF/Debt

-0.1974

Equity Multi

-3.9509

Rec Turnover

3.2187

Pay Turnover

1.8656

Inv Turnover

1.6911

FA Turnover

16.8620

Asset Turnover

0.6279

OCF/Share

-1.6762

FCF/Share

-2.0749

Cash/Share

0.6510

OCF/Sales

-0.2622

FCF/OCF

1.2379

CF Coverage

-0.1974

ST Coverage

-7.8104

CapEx Coverage

-4.2032

Div&CapEx Cov

-4.2032

P/BV

-0.9005

P/B

-0.9005

P/S

0.3439

P/E

-0.9561

P/FCF

-1.0593

P/OCF

-1.3841

P/CF

-1.3841

PEG

-0.0198

P/S

0.3439

EV Multiple

-7.7753

P/FV

-0.9005

DPS

0.0000

Latest Headlines (EST)

GlobeNewswire Inc. Dec 18, 16:30 Trinity Biotech Announces Management Changes

Revenue Product Segmentation

Dividend History

Cash Value Ex-Dividend Date Declaration Date Record Date Pay Date
0.22 06/05/2015 05/27/2015 06/09/2015 07/01/2015
0.22 06/06/2014 05/23/2014 06/10/2014 07/01/2014
0.20 06/06/2013 06/03/2013 06/10/2013 07/01/2013
0.15 06/06/2012 06/05/2012 06/08/2012 06/22/2012
0.40 06/07/2011 05/27/2011 06/09/2011 06/23/2011